Banks

KakaoBank Corp. Executives Purchase 460 Million Won Worth of Company Stock

"Committed to Enhancing Shareholder Value"

PARK JONG-HWA
2026-08-14 10:11:59
[Edaily Reporter PARK JONG-HWA ] KakaoBank Corp. executives have begun purchasing the company’s shares as part of their commitment to responsible management.
(Photo: KakaoBank Corp.)


KakaoBank Corp. announced on the 14th that 12 of its executives purchased 21,000 shares of the company’s stock on the open market between June and the 12th of this month. The total purchase amount was 464.83 million won. KakaoBank Corp. explained that the share purchases were made based on the executives’ confidence in the company’s mid- to long-term growth potential and their commitment to responsible management.

KakaoBank Corp. is diversifying its business portfolio with the goal of reaching 100 trillion won in assets next year and achieving a 15% return on equity (ROE) by 2030. Its entry into the non-bank lending business through the acquisition of Marston Capital last June is also part of these efforts.

KakaoBank Corp. spokesperson stated, “This share buyback reflects the executive team’s confidence in the company’s future growth potential and corporate value,” adding, “We will continue to strive to enhance corporate value and shareholder value through sustained innovation and stable growth.”

Economy

Corporation

IT·Science

Economy

[Market In] Turning to Bank Loans Instead of Corporate Bonds… Will Even A-Rated Companies Turn Their Backs on the Bond Market Next Year?

The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
2026-11-14 16:05:05

Corporation

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]

Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
2026-11-14 12:47:03

IT·Science

Samsung BioLogics Sees 96.8% Subscription Rate for 2.7 Trillion Won Rights Offering… Hanmi MASH New Drug Phase 2b Results [Weekly Biotech Roundup]

(Graphic: ChatGPT) During the second week of November (Nov. 9–13), the domestic pharmaceutical and biotech industry saw significant attention focused on the success of SAMSUNG BIOLOGICS(207940)’s …
2026-11-15 08:01:02